Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Definium Therapeutics, Inc.
Market Cap
$4.71B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.68B
Net Profit Margin
3.19%
TTM Avg
-1.95%
3Y Avg
-11.66%
5Y Avg
-17.12%
Market Cap
$4.65B
Net Profit Margin
3.68%
TTM Avg
3.96%
3Y Avg
4.48%
5Y Avg
3.62%
Market Cap
$4.59B
Net Profit Margin
8.43%
TTM Avg
-12.40%
3Y Avg
-46.69%
5Y Avg
-46.69%
Market Cap
$4.84B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.85B
Net Profit Margin
-1570.85%
TTM Avg
-4668.05%
3Y Avg
-2830.27%
5Y Avg
-2034.87%
Market Cap
$4.89B
Net Profit Margin
-139.18%
TTM Avg
-15.29%
3Y Avg
-73.58%
5Y Avg
-122.19%
Market Cap
$4.43B
Net Profit Margin
26.65%
TTM Avg
8.56%
3Y Avg
0.11%
5Y Avg
0.58%
Market Cap
$4.41B
Net Profit Margin
-20.73%
TTM Avg
-55.30%
3Y Avg
-87.73%
5Y Avg
-105.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.71B | 0.00% | 0.00% | 0.00% | 0.00% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 3.19% | -1.95% | -11.66% | -17.12% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 3.68% | 3.96% | 4.48% | 3.62% |
| BillionToOne, Inc. (BLLN)vs › | $4.59B | 8.43% | -12.40% | -46.69% | -46.69% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 0.00% | 0.00% | 0.00% | 0.00% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.85B | -1570.85% | -4668.05% | -2830.27% | -2034.87% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.89B | -139.18% | -15.29% | -73.58% | -122.19% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 26.65% | 8.56% | 0.11% | 0.58% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | -20.73% | -55.30% | -87.73% | -105.64% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
